03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: END08<br />

MultiStage: No<br />

DXCat Label: Hypoglycemia Specificity: B<br />

Etiology: Metabolic; Toxicologic; Neoplasm<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

1.01 Reactive or other hypoglycemia secondary Hypoglycemia<br />

DX 2512, 7750;<br />

to meals, abnormal nutrient metabolism, AND postgastrectomy history<br />

increased glucose utilization, chemicals or OR idiopathic "functional" hypoglycemia<br />

drugs, or deficient glucose production<br />

OR late hypoglycemia of maturity onset diabetes mellitus<br />

1.02 Hypoglycemia secondary to increased<br />

glucose utilization<br />

1.03 Reactive hypoglycemia secondary to<br />

abnormal nutrient metabolism<br />

Hypoglycemia<br />

AND exercise induced hypoglycemia<br />

OR fever induced hypoglycemia<br />

OR pregnancy induced hypoglycemia<br />

Hypoglycemia<br />

AND hereditary fructose intolerance<br />

OR fructose-1-phosphate aldolase deficiency<br />

OR galactosemia<br />

OR galactose-1-phosphate uridyl transferase deficiency<br />

OR leucine hypersensitivity<br />

OR branch chain ketonuria<br />

OR maple syrup urine disease<br />

DX 2511;<br />

DX 2511-2512 + GROUP FEVER;<br />

STAGE 1.01 + (DX 2703, 2711-<br />

2713, 2718-2719);<br />

1.04 Reactive hypoglycemia secondary to<br />

chemicals or drugs<br />

Hypoglycemia<br />

AND exogenous insulin administration<br />

OR exogenous insulin administration<br />

AND use of beta blocker drugs systemically<br />

OR use of oxytetracycline systemically<br />

OR use of ethylenediaminetetraacetic acid, systemically<br />

OR use of mebanazine systemically<br />

OR use of manganese systemically<br />

OR use of sulfonylurea systemically<br />

OR use of sulfonylurea systemically<br />

AND use of sulfisoxazole systemically<br />

OR use of dicumarol systemically<br />

OR use of phenylbutazone systemically<br />

OR use of ethyl alcohol systemically<br />

OR use of phenformin systemically<br />

OR use of pentamidine systemically<br />

OR use of disopyramide systemically<br />

OR use of quinine systemically<br />

NO;<br />

Thursday, January 07, 2010 9:21:25 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!